Do I need to order prothrombin time (PT) and activated partial thromboplastin time (APTT) before performing a closed reduction of an isolated nasal bone fracture in a patient without bleeding disorders or anticoagulant use?

No, PT/APTT Testing is Not Needed for Closed Nasal Bone Reduction

For an isolated nasal bone fracture requiring closed reduction in a patient without clinical indicators of bleeding risk (no personal/family history of bleeding disorders, no anticoagulant/antiplatelet use, no liver disease), routine PT/APTT testing is unnecessary and represents wasteful practice.

Clinical Decision Algorithm

Step 1: Assess for Bleeding Risk Indicators

Look specifically for:

• Personal history: Abnormal bleeding with prior procedures, easy bruising, prolonged bleeding from minor cuts
• Family history: Bleeding disorders (hemophilia, von Willebrand disease)
• Medication use: Warfarin, heparin, DOACs, antiplatelet agents (aspirin, clopidogrel)
• Medical conditions: Liver disease, kidney disease, known coagulation factor deficiencies

Step 2: Apply Evidence-Based Testing Criteria

Order PT only if:

• History of warfarin therapy
• Vitamin K-dependent clotting factor deficiency
• Liver disease
• History of abnormal bleeding 1

Order APTT only if:

• Current heparin treatment
• Hemophilia
• Lupus anticoagulant antibodies
• von Willebrand disease 1

Do NOT order if: Clinical assessment is negative for all above factors

Why Routine Testing is Inappropriate

The evidence strongly demonstrates that routine preoperative coagulation screening in patients without clinical indicators is not evidence-based:

• 94.3% of PT tests and 99.9% of APTT tests are unnecessary when performed on patients without relevant history and physical findings 1
• Among patients with no bleeding risk indicators, only 6.6% of PT and 7.1% of APTT tests reveal any abnormality, and most represent false positives rather than clinically significant findings 1
• Clinical assessment alone is sufficient for screening; coagulation tests should be reserved for investigating patients with positive clinical findings 2

The False Positive Problem

A critical pitfall: The prevalence of asymptomatic congenital coagulopathies is so low that false-positive results greatly outnumber true-positive results when screening low-risk patients 2. This leads to:

• Unnecessary procedure delays
• Additional costly testing
• Patient anxiety
• No improvement in clinical outcomes 3

Specific Context: Nasal Bone Reduction

Closed reduction of nasal bone fractures is a minor procedure with minimal bleeding risk. The available epistaxis guidelines 4, 5 focus on managing active nosebleeds and only recommend considering coagulation status when patients have:

• Known bleeding disorders
• Active anticoagulant/antiplatelet use
• Recurrent or severe epistaxis requiring intervention

A simple closed reduction in an otherwise healthy patient falls well below the threshold for routine coagulation testing.

Common Pitfalls to Avoid

1. Ordering tests "just to be safe": This habit-based ordering contributes to healthcare waste without improving patient safety 6
2. Routine preoperative panels: Studies show 70-81% of routine PT/APTT tests in hospitalized patients lack clinical indication 6
3. Acting on borderline abnormal results in low-risk patients: These are likely false positives and should not delay necessary procedures 3

When to Reconsider

Do obtain PT/APTT if during your clinical assessment you discover:

• Patient forgot to mention anticoagulant use
• History reveals easy bruising or prolonged bleeding from dental work
• Physical exam shows unexplained ecchymoses or petechiae
• Patient has known liver disease or chronic kidney disease

In these scenarios, the pretest probability of a true coagulation abnormality justifies testing 2, 7.